News Flaggemelding Staff August 22, 2025 Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA. Iframe sync Post navigation Previous: Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceNext: Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP) More Stories Clinical Trial Healthcare News Pharmaceutical Pregnancy Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options Staff December 27, 2025 Cancer Clinical Trial Healthcare News Nursing Pharmaceutical Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts Staff December 27, 2025 Cancer Fitness Healthcare News Nursing Nutrition Pharmaceutical Pregnancy Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026 Staff December 27, 2025
